Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (SEHK:1349) entered into a share transfer agreement to acquire a 90% stake in Shanghai Youni Bio-tech Co. Ltd. from Liang Jun, Zhang Yulin and Huang Xiaojin for CNY 22.5 million in cash on December 12, 2014. Of the purchase consideration, CNY 10.1 million is payable to Liang Jun, CNY 7.5 million to Zhang Yulin and CNY 4.9 million to Huang Xiaojin. The consideration will be funded from internal resources. Liang Jun will continue to hold a 10% stake in Shanghai Youni Bio-tech following the deal. For the year ending December 31, 2013, Youni Bio-tech reported an audited net asset value of CNY 16.29 million, audited net loss before and after taxation of CNY 4.02 million. The transaction is subject to approval by vendors.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (SEHK:1349) completed the acquisition of a 90% stake in Shanghai Youni Bio-tech Co. Ltd. from Liang Jun, Zhang Yulin and Huang Xiaojin in January 2015. The deal was approved by the Board of Shanghai Fudan.